Comings, Goings & Promotions
- Boland Named Chair of the Department of Radiology
- Somerville Steps Down as CNO, SVP of Patient Care Services; Morrissey to serve as Interim CNO
- Taylor Named Executive Director of Ambulatory Operations and Management for 60 Fenwood Road
- Manson, Adler Appointed Leadership Roles in Women’s Health
- George Q. Daley Appointed Dean of Faculty Medicine at Harvard Medical School
- New Division of Translational and Molecular Oncologic Pathology within the Department of Pathology
- Logsdon Named Director of Physician Assistant Services
- Johnson to Join UMMS
Giles Boland
Boland Named Chair of the Department of Radiology
Giles Boland, MD, FACR, has been named the BWHC chair of the Department of Radiology, effective Aug. 1.
Boland, an internationally recognized radiologist, joins BWHC from Massachusetts General Hospital, where he served as vice chair of Business Development, Abdominal Imaging and Interventional Radiology, and physician director of Network Development and Referral Management in Radiology.
“Dr. Boland’s focus on the emerging health care reform agenda and how providers can adapt their care systems to deliver better, more cost-effective patient outcomes dovetails directly and in a unique way with our strategic direction for the future,” said BWHC President Betsy Nabel, MD. “A talented and caring physician, he brings a depth of experience in patient care, research and teaching that will enrich the department and truly benefit the patients we serve.”
Boland received his medical degree from the London Hospital Medical College and completed his residency at Guy’s Hospital in London. He began his fellowship in Radiology at MGH in 1992, joining the faculty in 1994. A board-certified physician in Internal Medicine and Radiology, his clinical area of expertise is abdominal imaging—primarily oncology—with interests in the liver, pancreas and adrenal gland.
While at MGH, he spearheaded several programs in his department, including The Radiology Consulting Group, which provides national and international best-practices expertise in Radiology; the Drug Development program; teleradiology; and one of the largest academic outpatient programs in the country. He is also a co-founder of the MGH Global Health Radiology Program, which works with other MGH global health programs to address the unmet medical imaging needs and health care disparities for vulnerable and crisis-affected populations.
Boland has more than 130 publications and is associate editor for the Journal of the American College of Radiology. He sits on the American College of Radiology Imaging 3.0 task force, which aims at steering the practice of radiology toward the delivery of imaging appropriateness, quality, safety, efficiency and patient satisfaction.
He succeeds Steven Seltzer, MD, who announced his decision last July to transition from chair to faculty member in the department in July 2015.
Jackie Somerville
Somerville Steps Down as CNO, SVP of Patient Care Services; Morrissey to serve as Interim CNO
Jackie Somerville, PhD, RN, FAAN, chief nursing officer and senior vice president of Patient Care Services, has recently announced that she will step down from her leadership roles and pursue opportunities in academia and consulting, effective Oct. 1. Lisa Morrissey, DNP, MBA, RN, NEA-BC, associate chief nurse of Peri-Procedural Areas at BWH, Foxborough and 850 Boylston St., will serve as interim chief nursing officer.
Leo F. Buckley, Jr., MBA, executive director of Business Operations for Patient Care Services and Nursing, will support Morrissey by overseeing the business and operational aspects of Patient Care Services and non-clinical administration. Both Morrissey and Buckley will also continue their responsibilities in their current roles.
Throughout Somerville’s five and half years at BWH, she shepherded the hospital through several key initiatives. During the transition to Partners eCare, she ensured that Nursing and Patient Care Services were prepared for the dramatic clinical and operational changes so that patients continued to receive safe, high-quality care during the initial handoff and throughout the move.
Under her guidance, BWH was named as one of 13 national affiliates of the internationally recognized Watson Caring Science Institute in recognition of its commitment to caring science and caring practices for staff, patients, families and communities.
Lisa Morrissey
Somerville has mentored her fellow nurses on understanding the principles of caring science and learning to integrate those principles into their practices. Under her leadership, steps toward Magnet Recognition began in May 2015 and the application to pursue this designation was submitted to the American Nursing Credentialing Center in April 2016.
Interim CNO Morrissey joined BWH in 2013. She has overseen nursing practice in Perioperative Services, Cardiovascular Diagnostic Interventional Center, Interventional Radiology, the Pain Clinic, Endoscopy and Ambulatory Day Surgery at multiple BWH sites, leading staff members who care for more than 62,000 patients annually across the Brigham. Prior to joining BWH, she served as director of Nursing for the Operating Rooms at MGH, preceded by a decade at Beth Israel Deaconess Medical Center as a perioperative nurse, director for nursing in Perioperative Services and business director.
Buckley has been part of the Brigham for nearly two decades. Through the transition period, he will continue to focus on business operations, working closely with leaders in Nursing and Patient Care Services to support them as they continue to ensure delivery of high-quality, cost-effective and efficient care and services for our patients. Prior to coming to BWH, Buckley was director of nursing administration at Tufts New England Medical Center and a systems manager at Wang Laboratories.
Annemarie Austin, BSN, RN, clinical business director of Perioperative Services and a nurse leader for more than 20 years, will take on added responsibilities in the interim in the BWH Operating Rooms and procedural areas.
Jeffrey Taylor
Taylor Named Executive Director of Ambulatory Operations and Management for 60 Fenwood Road
Jeffrey Taylor, MPH, has been appointed executive director of Ambulatory Operations and Management for the new building, effective July 25.
In this role, Taylor will serve as the senior leader for all 60 Fenwood Road clinical operations, including Neurosciences; Orthopaedics; Rheumatology, Immunology and Allergy; Infusion Center; and Diagnostic Imaging. He will work closely with medical directors and administrative leadership in these areas. Taylor will oversee the practice management team, daily operations, financial performance and strategic planning across the new building.
Taylor, who joined the Brigham in 2008, worked previously as the Department of Orthopaedics practice administrator for the main campus and Foxborough, and then as director of Operations and Network Development in Orthopaedics and the Brigham Orthopaedic and Arthritis Center.
Prior to joining BWH, Taylor held several different management roles at St. Joseph Health Services in Rhode Island and was a practicing physical therapist.
Taylor received his master’s in public health from the University of New England and his bachelor’s in physical therapy from the University of Connecticut.
JoAnn Manson
Manson, Adler Appointed Leadership Roles in Women’s Health
JoAnn Manson, MD, MPH, DrPH, co-director of BWH’s Connors Center, chief in the Division of Preventive Medicine, and Michael and Lee Bell Professor of Women’s Health at HMS, was recently appointed interim executive director of the Connors Center for Women’s Health and Gender Biology. Dale Adler, MD, executive vice chair in the Department of Medicine, was appointed as interim chief of the Division of Women’s Health. Manson’s and Adler’s additional leadership roles are effective immediately.
Paula Johnson, MD, MPH, was previously executive director of the Connors Center for Women’s Health and Gender Biology and chief of the Division of Women’s Health before becoming the president of Wellesley College. A nationwide search was initiated to identify new leadership, and the search committee was led by co-chairs Terrie Inder, MD, chair of Pediatric Newborn Medicine, and Daphne Haas-Kogan, MD, chair of Radiation Oncology.
Manson is a highly regarded endocrinologist and epidemiologist and is known internationally as a preeminent leader and researcher in the field of women’s health. She is the principal investigator of several research studies, including the Women’s Health Initiative (WHI) center in Boston, the VITamin D and OmegA-3 TriaL (VITAL), the cardiovascular component of the Nurses’ Health Study and others.
Dale Adler
Adler is a distinguished clinician, educator, researcher and leader, having previously served as professor and chief of cardiology at Case Medical Center, Case Western Reserve University. In his role as executive vice chair, Adler has overseen hospital network development and institutional strategies, and he has identified new outreach opportunities for specialists and primary care physicians in coordination with BWH and the BWPO.
In his new role, Adler will work closely with Elinor Mody, MD, for clinical matters within the division and Janet Rich-Edwards, ScD, MPH, for research matters.
“We know that the Brigham community shares our great confidence and pride that both the Connors Center and the division will be in the capable hands of such admired and talented BWH leaders,” said BWHC Chief Academic Officer and Senior Vice President of Research, Paul Anderson, MD.
George Daley
George Q. Daley Appointed Dean of Faculty Medicine at Harvard Medical School
George Q. Daley, MD, PhD, of the Division of Hematology, has been selected as the dean of Faculty Medicine at Harvard Medical School, effective Jan. 1, 2017. In addition to his BWH appointment, Daley is also the director of the Stem Cell Transplantation Program at Boston Children’s Hospital and Dana-Farber Cancer Institute, as well as the Robert A. Stranahan Professor of Pediatrics at HMS.
Daley succeeds acting dean Barbara J. McNeil, who assumed the position Aug. 1, and dean Jeffrey S. Flier, who stepped down on July 31.
Daley has held various academic appointments in his tenure at HMS. He progressed through the ranks of professorship and became full professor of biological chemistry and molecular pharmacology in 2010. He has been a member of the faculty of the Harvard-MIT Division of Health Sciences and Technology (HST) since 1995, a founding member of the executive committee of the Harvard Stem Cell Institute since 2004, an associate member of the Broad Institute of Harvard and MIT, and a core faculty member of the Manton Center for Orphan Disease Research at Boston Children’s since 2009. He is also the associate chief of the Division of Pediatric Hematology/Oncology at Boston Children’s and Dana-Farber.
Daley’s research has led to important, scientific contributions in the realm of stem cells. He has been a key figure in developing international guidelines for conducting stem cell research and clinical translation of stem cells. In addition, he has testified before Congress and spoken at global forums about the scientific and ethical issues associated with stem cell research and its promise in treating diseases.
Daley holds his bachelor’s from Harvard University, received his medical degree from Harvard Medical School and his doctorate in Biology from the Massachusetts Institute of Technology. He completed his residency in internal medicine at Massachusetts General Hospital and was a clinical fellow at BWH and Boston Children’s.
New Division of Translational and Molecular Oncologic Pathology Within the Department of Pathology
BWH announced the launch of a new Division of Translational and Molecular Oncologic Pathology within the Department of Pathology, effective July 1. The division also serves as the Department of Oncologic Pathology at Dana-Farber Cancer Institute. Max Loda, MD, director of the Center for Molecular Oncology at BWH and DFCI, is the inaugural chair of the division, and Jon Aster, MD, PhD, chief of Hematopathology at BWH, serves as vice chair.
The new division reflects the increasingly central role of pathology and pathology research in combined cancer research and cancer care efforts. Both BWH and Dana-Farber have recruited a number of highly talented and collaborative academic pathologists who have become central to efforts in precision medicine, immunotherapy and basic cancer research. These individuals have held their primary academic appointments in the BWH Department of Pathology, but there was no academic home for them at Dana-Farber.
“The increasing number of faculty, coupled with increasingly broad research and clinical interactions with the Department of Pathology at the Brigham, underscored the need for a formal unit recognizing the importance of the role of pathology at Dana-Farber,” said Jeff Golden, MD, chief in the Department of Pathology.
Jessica Logsdon
Logsdon Named Director of Physician Assistant Services
Jessica Logsdon, MHS, MHA, PA-C, was recently appointed as the director of Physician Assistant (PA) Services, effectively immediately, following her position as interim director since 2015.
Logsdon joined BWH in 2005 as a physician assistant in the Department of Neurosurgery. She became chief physician assistant in 2011 after working on the inpatient floor and in the Neuroscience Intensive Care Unit. Logsdon previously served as associate director for Performance Improvement after completing several BWH-sponsored programs, including the Clinical Process Improvement Program, the Brigham Care Redesign Incubator and Startup Program (BCRISP) and the Brigham Leadership Program at Harvard Business School.
“Jessica has been a tireless advocate for both PA services and the BWH PAs,” said Chief Medical Officer Stanley W. Ashley, MD. “She has a deep commitment to the profession and to our patients. Through her efforts, patients have gained a better understanding of the critical role of a physician assistant in providing high quality, patient-centered care.”
Throughout her time at BWH, Ashley added, Logsdon has worked to increase transparency between leadership and BWH PAs; help individual departments restructure and/or enhance their own PA complements; streamline the PA student program; and to create a foundation for maintaining compliance for all PAs across the organization.
In her new role, Logsdon will continue to focus her efforts on improving the recruitment and retention of highly skilled physician assistants at BWH by collaborating with others across the organization. She will also continue to help define the relative roles of PA Services and the individual departments in PA oversight. Logsdon will continue to see Neurosurgery patients.
Logsdon earned her master’s in health science physician assistant from Quinnipiac University and her master’s in health care administration from Simmons College.
Mark Johnson
Johnson to Join UMMS
Mark Johnson, MD, PhD, in the Department of Neurosurgery, has accepted the position of chair in the Department of Neurosurgery at the University of Massachusetts Medical School and University of Massachusetts Memorial Medical Center, where he will also become a tenured professor.
Over his two decades career at BWH, Johnson built a practice focused on the care of patients with brain tumors and those who suffer from normal pressure hydrocephalus. As the director of the Adult Hydrocephalus Program, he was recognized with a gift from Susan and Rick Sontag of the Sontag Foundation—a foundation that supports and funds brain cancer and rheumatoid arthritis research—in 2013. Patients from around the world have been referred to this program.
Johnson is also a physician-scientist and has published on scientific discoveries related to the role of noncoding RNAs and signal transduction pathways in gliomagenesis (the formation and development of gliomas).
“Although we are sad to see Mark go, we are proud that he was selected as a leader for a Neurosurgery Department at one of the premier medical schools,” said E. Antonio Chiocca, MD, PhD, FAANS, chief in the Department of Neurosurgery.
Johnson received his medical degree from Harvard Medical School and his PhD in Neurobiology from Harvard University.